This legal story began in July 2018, when Luminati (now Bright Data) filed its first lawsuit against Oxylabs, alleging patent infringement. From the very beginning, Oxylabs has consistently maintained that it has not infringed any of Bright Data’s patents and has also alleged these patents' invalidity.
That first case concluded with a settlement in which all claims and counterclaims were dismissed with prejudice, signaling a clear resolution. However, Bright Data continued to pursue additional lawsuits based on similar patent claims. Oxylabs in turn challenged the validity of Bright Data’s patents before the issuing institution - the U.S. Patent Office (USPTO).
Fast forward to now, in August 2025, the U.S. Court of Appeals for the Federal Circuit has upheld the USPTO invalidation of key Bright Data patents purportedly covering residential proxy technologies - the same patents that underpinned ongoing litigation, primarily Case No. 395. This decision further affirms the strength of our position and also underscores the importance of fair competition and innovation.
We remain fully committed to protecting our technology, our clients, and the broader market. Oxylabs will continue to use every legal avenue to ensure fair competition and to support a business environment driven by innovation.
Julius Cerniauskas
CEO at Oxylabs
Resolved by settlement
Bright Data (formerly known as Luminati) v. Oxylabs
Bright Data (formerly known as Luminati) sued Oxylabs, claiming that Oxylabs' residential proxy network service and Real-Time Crawler allegedly infringed Bright Data's two patents U.S. Patents 9,241,044 and 9,742,866.
Stayed
Bright Data (formerly known as Luminati) v. Oxylabs
Bright Data (formerly known as Luminati) filed a new patent lawsuit against Oxylabs, claiming that Oxylabs' residential proxy network service and Real-Time Crawler allegedly infringed upon three additional Bright Data patents, U.S. Patents 10,469,614, 10,257,319, 10,484,510.
Stayed and administratively closed
Bright Data (formerly known as Luminati) v. Oxylabs
Bright Data (formerly known as Luminati) filed a new patent lawsuit against Oxylabs, claiming that Oxylabs' data center IP technologies allegedly infringed on additional Bright Data patents, U.S. Patents 10,484,511 10,637,968.
Resolved by parties' agreement
Oxylabs v. Bright Data (formerly known as Luminati)
Oxylabs sued Bright Data (formerly known as Luminati) and its investor EMK Capital on the following claims: unfair competition, false advertising, false patent marking. defamation/business disparagement, tortious interference with prospective business relations, tortious interference with the existing contract, breach of contract, and conspiracy.
Ongoing
Oxylabs v. Bright Data (formerly known as Luminati)
Oxylabs has filed a lawsuit against Bright Data (formerly known as Luminati) claiming the infringement of three patents of Oxylabs. Oxylabs alleges that its competitor infringes on Oxylabs’ patents, U.S. Patents 9,503,498, 9,516,091, 10,601,948, claiming Smart Proxy Rotator and web script management technologies for the provisioning of web scraping and other business services.
Ongoing
Bright Data (formerly known as Luminati) v. Oxylabs
After the Court rejected Bright Data’s (formerly known as Luminati) attempt to file its patent infringement allegations as a counterclaim against Oxylabs in case No. 011, Bright Data’s allegations were severed into a separate lawsuit. In this new case, Bright Data claims that Oxylabs’ accused services infringe Bright Data’s U.S. Patent 11,206,317.
For its counterclaims in this case, Oxylabs accuses Bright Data of infringing Oxylabs’ U.S. Patents 7,010,526 and 7,020,667 which claim technology relating to knowledge-based data mining and data retrieval/collection.
July 19, 2018
Case No. 299
Luminati (now known as Bright Data) sued Oxylabs, claiming that two Oxylabs’ products - Oxylabs’ residential proxy network service and Real-Time Crawler - allegedly infringed Luminati’s two patents, U.S. Patents 9,241,044 and 9,742,866.
August 21, 2019
Case No. 299
The Court issued its claim construction[1] opinion (a so-called Markman[2] opinion), which proved to be critical for the later stages of Case No. 299. With this decision, at Oxylabs’ request, the Court invalidated one of the three independent claims of Luminati’s (now known as Bright Data) patents (Claim 108) as indefinite and issued an order construing the claims of Luminati’s patents.
September 09, 2019
Case No. 299
Oxylabs filed its Motion for Judgment on the Pleadings[3] (a so-called Alice Motion[4]) seeking a ruling that Luminati's (now known as Bright Data) patents were invalid for impermissibly claiming an abstract idea.
November 04, 2019
Case No. 299
Oxylabs also filed a Motion for Summary Judgment that Oxylabs did not infringe Luminati's (now known as Bright Data) patents. Both motions (i.e., Motion for Judgment on the Pleadings and Motion for Summary Judgment) were pending, and if the Court had granted either of them, the lawsuit would have concluded on the merits in Oxylabs’ favor.
November 05, 2019
Case No. 299
On December 12, 2018, in Case No. 299, Luminati (now known as Bright Data) asserted certain non-patent claims against Oxylabs. Oxylabs wrote to Luminati on September 10, 2019, and advised that these additional claims asserted in Case No. 299 were frivolous and that the continued pursuit of the claims would subject Luminati to liability for Oxylabs’ attorney’s fees. On November 4, 2019, rather than pursue these additional non-patent claims asserted in Case No. 299, Luminati voluntarily withdrew them without prejudice.
Luminati (now known as Bright Data) filed two new patent lawsuits against Oxylabs, claiming that Oxylabs’ technologies allegedly infringed on five additional patents, U.S. Patents 10,469,614, 10,257,319, 10,484,510 (Case No. 395) and 10,484,511 10,637,968 (Case No. 396). In Case No. 395, Luminati also once again asserted the same additional non-patent claims, which Luminati voluntarily withdrew in Case No. 299 back in November 2019.
January 03, 2020
Case No. 299
During the Pretrial Conference[5] (one month before jury trial), the parties resolved Case No. 299 by settlement. Therefore, all pending motions were not resolved on their merits.
February 04, 2020
Case No. 299
As the settlement was reached by both parties, Case No. 299 was dismissed with prejudice in accordance with the parties’ settlement agreement. An important point to note is that Luminati's (now known as Bright Data) agreed to resolve the case while fully understanding that it can never again assert infringement against Oxylabs’ accused products on the same patents.
March 05, 2020
Case No. 73
After witnessing what we believed to be continuous efforts of Luminati's (now known as Bright Data) to mislead the market regarding Oxylabs’ products, Oxylabs sued Luminati and its investor EMK Capital LLP on the following claims: unfair competition, false advertising, false patent marking, defamation/business disparagement, tortious interference with prospective business relations, tortious interference with the existing contract, breach of contract, and conspiracy (Case No. 73).
May 26, 2020
Case No. 395
Oxylabs filed antitrust counterclaims against Luminati (now known as Bright Data), and claims against Luminati’s investor EMK Capital LLP and Hola (Hola VPN Ltd. and Hola Networks Ltd.) in Case No. 395. The claims asserted by Oxylabs include: violation and conspiracy to violate the antitrust laws of the United States, monopolization and attempted monopolization of the residential proxy marketplace, and the filing of sham patent-infringement lawsuits against competitors, including Oxylabs. To promote fair marketplace practices, Oxylabs sought to redress the injuries it has suffered and hold Luminati, EMK Capital, and Hola accountable for their actions.
December 07, 2020
Case No. 395
The Court issued its Claim Construction Opinion and Order, which will be critical for the later stages of Case No.395. This decision invalidated one of the patent claims asserted by Luminati (now known as Bright Data).
April 19, 2021
Case No. 73
All parties involved in Case No. 73 agreed on a stipulation which ended the case. Therefore, all pending motions were not resolved on their merits.
April 19, 2021
Case No. 395
Bright Data (formerly known as Luminati) and Oxylabs dismissed their non-patent claims through stipulation. Oxylabs’ antitrust claims against EMK were dismissed after the Court found that EMK could not conspire under the antitrust laws with its related entity, Bright Data.
July 01, 2021
Case No. 396
The parties filed a Joint Stipulation and Motion to Dismiss With Prejudice Patent Infringement Claims Against Metacluster LT, UAB (the “Stipulation”). In the Stipulation, Bright Data (formerly known as Luminati) represented what acts it accused of infringement and Metacluster represented that it had not performed any such acts. Subject to the Stipulation, Bright Data moved to dismiss its claims of infringement against Metacluster with prejudice, and defendants agreed to the dismissal. Based on the parties’ Stipulation, the Court entered an Order on July 2, 2021, dismissing Bright Data’s claims against Metacluster with prejudice.
November 05, 2021
Case No. 395
The jury issued a verdict finding certain claims infringed and not invalid. While we are disappointed in the decision, we thank the jury for their service. We note that the jury’s decision relates solely to a claim for monetary damages. Oxylabs is legally entitled to continue providing the accused services. The Court has not issued any orders related to continued use of Oxylabs’ residential proxy service. We intend to continue to pursue our positions both with the District Court and, if necessary, at the Court of Appeals. Oxylabs continues to offer its services in an uninterrupted manner.
January 07, 2022
Case No. 011
Oxylabs has filed the lawsuit against Bright Data (formerly known as Luminati) claiming the infringement of three patents of Oxylabs. Oxylabs alleges that its competitor infringes on Oxylabs’ patents claiming Smart Proxy Rotator and web script management technologies for the provisioning of web scraping and other business services.
February 10, 2022
Case No. 395
On February 10, 2022, the District Court entered an Order denying Bright Data’s (formerly known as Luminati) request for an injunction. The Order is available here.
September 06, 2022
Case No. 396
The Court issued a sua sponte order staying and administratively closing Case No. 396 (concerning the alleged infringement of Bright Data (formerly known as Luminati) patents on data center IP technologies) pending any appeal and entry of a final and non-appealable judgment in Case No. 395 (concerning the alleged infringement of Bright Data patents on residential proxy technologies).
February 28, 2023
Case No. 395
On February 28, 2023, the Court issued a sua sponte order staying the case until the ultimate resolution in each of the USPTO proceedings (i.e., IPRs and EPR) concerning the validity of Bright Data’s (formerly known as Luminati) patents that are asserted against Oxylabs in the case. A summary and the status of all of the USPTO proceedings challenging the validity of the Bright Data patents asserted against Oxylabs in Case No. 395 (i.e., patents No. 10,257,319, No. 10,484,510 and No. 10,469,614) can be found in the table below.
April 14, 2023
Case No. 171
After the Court rejected Bright Data’s (formerly known as Luminati) attempt to file its patent infringement allegations as a counterclaim against Oxylabs in Case No. 011, Bright Data’s allegations were severed into a separate lawsuit (Case No. 171). In this new case, Bright Data claims that Oxylabs’ accused services infringe Bright Data’s U.S. Patent 11,206,317.
April 28, 2023
Case No. 171
On April 28, 2023 Oxylabs filed its counterclaims against Bright Data in the newly severed case. Oxylabs accuses Bright Data of infringing Oxylabs’ U.S. Patents 7,010,526 and 7,020,667 which claim technology relating to knowledge-based data mining and data retrieval/collection.
July 07, 2023
Case No. 011
The Court issued Claim Construction Order in the Case No. 011. By this order the Court provided instructions on the precise scope and meaning of the claims.
December 03, 2024
Case No. 171
Oxylabs filed an opposed motion to stay the case. The motion is based on the patent ‘317 validity challenge before the U.S. Patent Office and its results favorable to Oxylabs. Final office action was issued on April 10, 2025 rejecting all ‘317 patent claims asserted against Oxylabs.
August 01, 2025
Case No. 395
The U.S. Court of Appeals for the Federal Circuit affirmed earlier U.S. Patent Office decisions invalidating claims from two patents held by Bright Data allegedly related to residential proxy technologies. These patents were the basis of Bright Data’s infringement allegations against Oxylabs in Case No. 395.
Patent | USPTO actions | Status | Relevant to Case Nos. |
---|---|---|---|
10,257,319 | IPR No. IPR2021-01492 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | 395 |
IPR No. IPR2022-00135 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | ||
IPR No. IPR2022-00915 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | ||
EPR No. 90/014,875 | Instituted but has been stayed on April 7, 2022 until the resolution of IPR2021-01492 | ||
10,484,510 | IPR No. IPR2021-01493 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | 395 |
IPR No. IPR2022-00138 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | ||
IPR No. IPR2022-00916 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | ||
EPR No. 90/014,876 | Instituted but has been stayed on April 7, 2022 until the resolution of IPR2021-01493 | ||
10,469,614 | EPR. No. 90/014,880 | Final office action issued on June 27, 2022 rejecting all claims asserted against Oxylabs | 395 |
10,484,511 | EPR No. 90/014827 & 90/014624 | Final office action issued on June 21, 2022 rejecting all claims asserted against Oxylabs | 396 |
10,637,968 | EPR No. 90/014,816 & 90/014,652 | Final office action issued on September 29, 2022 rejecting all claims asserted against Oxylabs | 396 |
11,206,317 | EPR No. 90/019,478 | Final office action issued on April 10, 2025 rejecting all claims asserted against Oxylabs | 171 |
11,044,342 | IPR No. IPR2022-00103 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | N/A |
11,044,344 | IPR No. IPR2022-00353 | Decision by the U.S. Court of Appeals for the Federal Circuit on August 1, 2025, affirming the USPTO decision determining all the challenged claims unpatentable | N/A |
11,190,622 | IPR No. IPR2022-00687 | Final written decision by the USPTO issued on October 4, 2023 determining all the challenged claims unpatentable | N/A |
11,616,826 | IPR2024-00126 | Final written decision by the USPTO issued on June 12, 2025 determining all the challenged claims unpatentable | N/A |
11,272,034 | PGR No. PGR2022-00052 | Final written decision by the USPTO issued on March 19, 2024 cancels all claims of the patent | N/A |
11,349,953 | PGR No. PGR2022-00061 | Final written decision by the USPTO issued on March 14, 2024 cancels some of the original claims and allows some of the new claims | N/A |
1. Claim Construction Order is the process of giving meaning to a patent’s claims by defining selected claim terms.
2. Markman Hearing is a pretrial hearing in a U.S. District Court during which a judge examines evidence from all parties on the appropriate meanings of relevant keywords used in a patent claim. “Markman” comes from the United States Supreme Court’s decision in Markman v. Westview Instruments, Inc., 517 U.S. 370 (1996), which held that it is up to the Court (as opposed to a jury) to interpret a patent’s claims. A Markman hearing is also known as a “claim construction hearing.”
3. Motion for Judgment on the Pleadings/Motion to Dismiss are motions that a party to a lawsuit may file, asking the Court to dismiss the case before it proceeds to discovery and a trial. They are motions taking issue with a party’s claim as a matter of law.
4. Alice Motion refers to the United States Supreme Court’s decision in Alice Corp. Pty. Ltd. v. CLS Bank Int’l, 573 U.S. 208 (2014), which held that a trial court must determine whether a patent is invalid for claiming unpatentable subject matter. The trial court must first determine whether the challenged claims “are directed to a patent-ineligible concept,” i.e., an abstract idea. If the claims are directed to an abstract idea, the Court then must determine whether the claims recite “additional elements” that “transform the nature” of the claims into a patent-eligible application of the abstract idea.
5. Pretrial conference is a Court hearing with the Judge and the parties to a case conducted prior to trial.
6. Inter Partes Review (IPR) - Inter partes review is a trial proceeding conducted at the Patent Trial and Appeals Board to review the patentability of one or more claims in a patent only on a ground that could be raised under §§ 102 or 103, and only on the basis of prior art consisting of patents or printed publications.
7. Ex Partes Reexamination (EPR) - Ex parte reexamination may be requested by either a patent owner or a third party in order to challenge the novelty or nonobviousness of one or more claims in a patent. The scope of prior art submitted in support of the challenge is limited to printed publications and patents, while other types of prior art (such as product prior art) cannot be raised in a request for ex parte reexamination.
8. Post Grant Review (PGR) – With respect to newer issued patents, Post Grant Review process begins with a third party filing a petition on or prior to 9 months after the grant of the patent or issuance of a reissue patent. A post grant review may be instituted upon a showing that it is more likely than not that at least one claim challenged is unpatentable.
Charhon Callahan Robson & Garza is a Dallas, Texas based law firm that handles business and intellectual-property litigation. Since its founding in 2013, CCRG has represented leading corporations — including Berkshire Hathaway companies (McLane and MBM), Ericsson, Samsung, OpenTable, Denbury, Cloudflare, and VTech — in business and intellectual-property disputes. The firm regularly litigates patent-infringement lawsuits on its clients’ behalves across the United States, including in the Eastern District of Texas, District of Delaware, and Northern District of California.
Proxies
Advanced proxy solutions
Data Collection
Datasets
Resources
Innovation hub